Tag Archives: depression

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »

Increased Identification of Women with Perinatal Depression, But Still Room for Improvement

Over the last decade, public awareness of the mental health challenges women face has grown tremendously, and we can say with certainty that we have succeeded in putting this important topic firmly on the medical map.  Still, the field of women’s mental health faces important challenges. How can we best serve women and the clinicians… Read More »

Medical News Today: Working long hours increases depression risk in women

Women who clock 55 working hours or more every week might have a higher risk of depression. Also, working weekends can increase depression risk for both men and women. Working longer hours may impact mental health, especially for women. A new study that now appears in the Journal of Epidemiology & Community Health found that… Read More »